NL-OMON55156招募中不适用
oCAlly advanced and recurrent Rectal cancer NAVigationAL surgery - a pilot study. - The CARNAVAL study.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Male or female
- •2. Age >= 18 years
- •3. Primary cT4abN0-2 rectal cancer or recurrent rectal cancer with an
- •indication for resection after neoadjuvant treatment
- •4. Lithotomy position during the whole procedure
- •5. Laparoscopic approach
- •6. Laparotomic approach
- •7. Signed informed consent (addendum 15)
排除标准
- •1. Threatened anterior circumferential resection margin negated through the
- •performance of a (posterior) pelvic exenteration
- •2. Tumor involvement sacrum cranial to the junction of S2/S3 and cT4b
- •3. Tumor involvement of common or external iliac artery/vein
- •4. Tumor involvement of hypogastric artery bilaterally
- •5. Tumor involvement of the lumbosacral plexus, sacral nerve 1, sacral nerve 2
- •or sacral nerve 3
- •6. Patient operated in semi-elective or acute setting
- •7. Inclusion in another study (randomised clinical trial)
- •8. Patient classified as American Society of Anaesthesiologist Class >= 4
- •9. Patient is unable to speak or understand Dutch
- •10. Legally incapable
研究者
相似试验
尚未招募
不适用
oCAlly advanced and recurrent Rectal cancer NAVigationAL Surgery – A Pilot Study (CARNAVAL)ocally advanced and recurrent rectal cancerNL-OMON28183ot applicable5
尚未招募
不适用
ateral Nodal Recurrence in Rectal CancerRectal cancerNL-OMON21039one157
尚未招募
不适用
Refractory advanced colorectal cancer in the treatment with integrated traditional Chinese and western medicine: a multi-center clinical studycolorectal cancerITMCTR2200006741onghua Hospital, Shanghai University of Traditional Chinese Medicine
进行中（未招募）
1 期
behandling af patienter med avanceret rectumcancer med capecitabin og oxaliplatin før under og efter kurativt intenderet strålebehandling, samt tillæg af cetuximab til patienter der er K-RAS vild-typewe will give capecitabine and oxaliplatin togehter with radiation to patient with rectum cancer T3 and T4. We will add cetuximab to patients who are K-RAS wild-typeMedDRA version: 9.1Level: LLTClassification code 10002124Term: Anal canal cancerEUCTR2009-010976-94-DKherlev hospital60
招募中
2 期
Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal CancerLocally Advanced Rectal CarcinomaCirculating Tumor DNANCT05601505Peking Union Medical College Hospital470